Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
This report contains market size and forecasts of Atropine in global, including the following market information:
Global Atropine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Atropine Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Atropine companies in 2021 (%)
The global Atropine market was valued at 515.5 million in 2021 and is projected to reach US$ 459.6 million by 2028, at a CAGR of -1.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atropine include C?PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International and SAURAV CHEMICALS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Atropine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atropine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Atropine Market Segment Percentages, by Type, 2021 (%)
Injection
Drop
Gel
Global Atropine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Atropine Market Segment Percentages, by Application, 2021 (%)
Gastrointestinal
Ophthalmology
Other
Global Atropine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Atropine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atropine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Atropine revenues share in global market, 2021 (%)
Key companies Atropine sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Atropine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
C?PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century

5 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here